The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Primary pyomyositis in North India: a clinical, microbiological, and outcome study

  • Kumar, Susheel (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research) ;
  • Bhalla, Ashish (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research) ;
  • Singh, Rajveer (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research) ;
  • Sharma, Navneet (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research) ;
  • Sharma, Aman (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research) ;
  • Gautam, Vikas (Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research) ;
  • Singh, Surjit (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research) ;
  • Varma, Subhash (Department of Internal Medicine, Postgraduate Institute of Medical Education and Research)
  • Received : 2015.12.24
  • Accepted : 2016.07.13
  • Published : 2018.03.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Pyomyositis is an infective condition with primary involvement of the skeletal muscles. There is sparse recent literature on patients with pyomyositis. Methods: This study was carried out at emergency services of a tertiary care center located in subtropical area of Indian subcontinent. Results: Sixty-two patients of primary pyomyositis formed the study cohort. Mean age of occurrence was $29.9{\pm}14.8years$. There were 54 men. Twelve patients had underlying medical diseases. Muscle pain was seen in all 62 patients. Forty-eight patients (77.4%) had the fever. Most common site of involvement was thigh muscles (n = 29, 46.8%). Forty-nine patients (79%) presented in the suppurative stage of illness. Patients with comorbidities were older (age: median 36 years [interquartile range (IQR), 25 to 47] vs. 24 years [IQR, 16 to 35], p = 0.024), had higher culture positivity with gram-negative organisms (8/9 [88.89%] vs. 6/29 [20.69%], p = 0.001). Importantly, higher number of these patients received inappropriate antibiotics initially. Patients with positive pus culture result had higher complication rate (32/38 [84.21%] vs. 10/18 [55.56%], p = 0.044). Six patients (9.7%) had in-hospital mortality. Lower first-day serum albumin, initial inappropriate antibiotic therapy, and advanced form of the disease at presentation were associated with increased in-hospital mortality. Conclusions: Primary pyomyositis is not an uncommon disease entity. Patients with comorbidities were more likely to receive initial inappropriate antibiotic therapy. Patients with positive pus culture report had the higher rate of complications. Lower first-day serum albumin, initial inappropriate antibiotic therapy and advanced form of the disease at presentation were associated with increased in-hospital mortality.

Keywords

References

  1. Bickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone Joint Surg Am 2002;84-A:2277-2286.
  2. Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis tropicans): current perspective. Postgrad Med J 2004;80:267-270. https://doi.org/10.1136/pgmj.2003.009274
  3. Agarwal V, Chauhan S, Gupta RK. Pyomyositis. Neuroimaging Clin N Am 2011;21:975-983. https://doi.org/10.1016/j.nic.2011.07.011
  4. Malhotra P, Singh S, Sud A, Kumari S. Tropical pyomyositis: experience of a tertiary care hospital in north-west India. J Assoc Physicians India 2000;48:1057-1059.
  5. Sharma A, Kumar S, Wanchu A, et al. Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol 2010;29:45-51. https://doi.org/10.1007/s10067-009-1277-x
  6. Chiedozi LC. Pyomyositis: review of 205 cases in 112 patients. Am J Surg 1979;137:255-259. https://doi.org/10.1016/0002-9610(79)90158-2
  7. Gambhir IS, Singh DS, Gupta SS, Gupta PR, Kumar M. Tropical pyomyositis in India: a clinico-histopathological study. J Trop Med Hyg 1992;95:42-46.
  8. Chattopadhyay B, Mukhopadhyay M, Chatterjee A, Biswas PK, Chatterjee N, Debnath NB. Tropical pyomyositis. N Am J Med Sci 2013;5:600-603. https://doi.org/10.4103/1947-2714.120796
  9. Martinez-de Jesus FR, Mendiola-Segura I. Clinical stage, age and treatment in tropical pyomyositis: a retrospective study including forty cases. Arch Med Res 1996;27:165-170.
  10. Crum NF. Bacterial pyomyositis in the United States. Am J Med 2004;117:420-428. https://doi.org/10.1016/j.amjmed.2004.03.031
  11. Hall RL, Callaghan JJ, Moloney E, Martinez S, Harrelson JM. Pyomyositis in a temperate climate: presentation, diagnosis, and treatment. J Bone Joint Surg Am 1990;72:1240-1244. https://doi.org/10.2106/00004623-199072080-00018
  12. Unnikrishnan PN, Perry DC, George H, Bassi R, Bruce CE. Tropical primary pyomyositis in children of the UK: an emerging medical challenge. Int Orthop 2010;34:109-113. https://doi.org/10.1007/s00264-009-0765-6
  13. Block AA, Marshall C, Ratcliffe A, Athan E. Staphylococcal pyomyositis in a temperate region: epidemiology and modern management. Med J Aust 2008;189:323-325.
  14. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESKEY ICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003;31:1250-1256. https://doi.org/10.1097/01.CCM.0000050454.01978.3B
  15. Chiu SK, Lin JC, Wang NC, Peng MY, Chang FY. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. J Microbiol Immunol Infect 2008;41:286-293.
  16. Markanday A. Acute phase reactants in infections: evidence- based review and a guide for clinicians. Open Forum Infect Dis 2015;2:ofv098. https://doi.org/10.1093/ofid/ofv098
  17. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004;17:432-437. https://doi.org/10.1111/j.0894-0959.2004.17603.x
  18. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000;85:599-610. https://doi.org/10.1093/bja/85.4.599
  19. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985;1:781-784.
  20. Jevons MP. "Celbenin": resistant staphylococci. Brit Med J 1961;1:124-125.
  21. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982;96:11-16. https://doi.org/10.7326/0003-4819-96-1-11
  22. Herold BC, Immergluck LC, Maranan MC, et al. Community- acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598. https://doi.org/10.1001/jama.279.8.593
  23. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008;46:787-794. https://doi.org/10.1086/528716
  24. Saiman L, O'Keefe M, Graham PL 3rd, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37:1313-1319. https://doi.org/10.1086/379022
  25. Huang H, Flynn NM, King JH, Monchaud C, Morita M, Cohen SH. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 2006;44:2423-2427. https://doi.org/10.1128/JCM.00254-06
  26. Zalavras CG, Rigopoulos N, Poultsides L, Patzakis MJ. Increased oxacillin resistance in thigh pyomyositis in diabetic patients. Clin Orthop Relat Res 2008;466:1405-1409. https://doi.org/10.1007/s11999-008-0198-3
  27. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin- resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003;37:1453-1460. https://doi.org/10.1086/379321
  28. Wolkewitz M, Frank U, Philips G, Schumacher M, Davey P; BURDEN Study Group. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 2011;66:381-386. https://doi.org/10.1093/jac/dkq424
  29. Chen SY, Wang JT, Chen TH, et al. Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia. Medicine (Baltimore) 2010;89:285-294. https://doi.org/10.1097/MD.0b013e3181f1851e
  30. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-59. https://doi.org/10.1086/345476
  31. Vigil KJ, Johnson JR, Johnston BD, et al. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010;50:374-380. https://doi.org/10.1086/649866
  32. Chiu NC, Hsieh MC, Chi H, Huang FY. Clinical characteristics of pyomyositis in children: 20-year experience in a medical center in Taiwan. J Microbiol Immunol Infect 2009;42:494-499.
  33. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703. https://doi.org/10.1016/S0895-4356(97)00015-2
  34. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003;237:319-334

Cited by

  1. Primary Pyomyositis: Contact Sports as the Rare Risk Factors vol.2019, pp.None, 2018, https://doi.org/10.1155/2019/5739714
  2. The double burden of diabetes and global infection in low and middle-income countries vol.113, pp.2, 2018, https://doi.org/10.1093/trstmh/try124
  3. Factors associated with pyomyositis: A systematic review and meta‐analysis vol.26, pp.10, 2018, https://doi.org/10.1111/tmi.13669